SciELO - Scientific Electronic Library Online

 
vol.12 issue1Primary leiomyosarcoma of the mandible: A case reportClinical and radiological course in apicoectomies with the Erbium: YAG LASER author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicina Oral, Patología Oral y Cirugía Bucal (Internet)

On-line version ISSN 1698-6946

Abstract

GRANJA PORTO, Gabriela; CAVALCANTI DO EGITO VASCONCELOS, Belmiro; AMORIM GOMES, Ana Cláudia  and  ALBERT, Daniela. Evaluation of lidocaine and mepivacaine for inferior third molar surgery. Med. oral patol. oral cir.bucal (Internet) [online]. 2007, vol.12, n.1, pp.60-64. ISSN 1698-6946.

Objective: The aim of this study was to compare 2% lidocaine and 2% mepivacaine with 1:100,000 epinephrine for postoperative pain control. Study design: A group of 35 patients, both genders were recruited, whose had ages ranged from 13 to 27 years-old and had two inferior third molars in similar positions to be extracted. The cartridges were distributed to the patients according to a randomised pattern, where lidocaine was in the control group and mepivacaine in the experimental group. Results: Results showed no significant association between the anesthetics and postoperative pain, pulp sensibility after one hour, gender, tooth position and duration of the surgical procedure. Conclusions: It was shown that lidocaine and mepivacaine have similar time of anesthesia, they are adequate for surgical procedures that last one hour, and there was no difference between the two anesthetics in relation to the severety of post-operative pain.

Keywords : Local anesthetics; post-operative pain/surgery; lidocaine/therapeutic use; mepivacaine/therapeutic use; third molar/surgery.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License